Regarding CRC prognosis and its metastasis, the CCR5 axis has earned considerable attention over the last few years as a novel biomarker and therapeutic option (Cambien et al. 2011; Chen et al. 2019; Nishikawa et al. 2019; Zimmermann et al. 2010). The gene discussed is CCR5; the disease is colorectal carcinoma.